Skip to main content
Top
Published in: Inflammation 3/2012

01-06-2012

Mast-Cell-Releasing Tryptase Triggers Acute Lung Injury Induced by Small Intestinal Ischemia–Reperfusion by Activating PAR-2 in Rats

Authors: Xiaoliang Gan, Dezhao Liu, Pinjie Huang, Wanling Gao, Xinzhi Chen, Ziqing Hei

Published in: Inflammation | Issue 3/2012

Login to get access

Abstract

Mast cell has been demonstrated to be involved in the small intestinal ischemia–reperfusion (IIR) injury, however, the precise role of tryptase released from mast cell on acute lung injury(ALI) induced by IIR remains to be elucidated, our study aimed to observe the roles of tryptase on ALI triggered by IIR and its underlying mechanism. Adult SD rats were randomized into sham-operated group, sole IIR group in which rats were subjected to 75 min superior mesenteric artery occlusion followed by 4 h reperfusion, or IIR being respectively treated with cromolyn sodium, protamine, and compound 48/80. The above agents were, respectively, administrated intravenously 5 min before reperfusion. At the end of experiment, lung tissue was obtained for assays for protein expressions of tryptase and mast cell protease 7 (MCP7) and protease-activated receptor 2 (PAR-2). Pulmonary mast cell number and levels of IL-8 were quantified. Lung histologic injury scores and lung water content were measured. IIR resulted in lung injury evidenced as significant increases in lung histological scores and lung water contents, accompanied with concomitant increases of expressions of tryptase and MCP7, and elevations in PAR-2 expressions and IL-8 levels in lungs. Stabilizing mast cell with cromolyn sodium and inhibiting tryptase with protamine significantly reduced IIR-mediated ALI and the above biochemical changes while activating mast cell with compound 48/80 further aggravated IIR-mediated ALI and the increases of above parameters. Tryptase released from mast cells mediates ALI induced by intestinal ischemia–reperfusion by activating PAR-2 to produce IL-8.
Literature
1.
go back to reference Barlos, D., E.A. Deitch, A.C. Watkins, F.J. Caputo, Q. Lu, B. Abungu, I. Colorado, D.Z. Xu, and R. Feinman. 2009. Trauma-hemorrhagic shock-induced pulmonary epithelial and endothelial cell injury utilizes different programmed cell death signaling pathways. American Journal of Physiology. Lung Cellular and Molecular Physiology 296: L404–L417.PubMedCrossRef Barlos, D., E.A. Deitch, A.C. Watkins, F.J. Caputo, Q. Lu, B. Abungu, I. Colorado, D.Z. Xu, and R. Feinman. 2009. Trauma-hemorrhagic shock-induced pulmonary epithelial and endothelial cell injury utilizes different programmed cell death signaling pathways. American Journal of Physiology. Lung Cellular and Molecular Physiology 296: L404–L417.PubMedCrossRef
2.
go back to reference Douzinas, E.E., S.E. Orfanos, O. Livaditi, K. Augustatou, V. Villiotou, N. Kavantzas, A. Flevari, P. Korkolopoulou, C. Roussos, and E. Patsouris. 2009. Hypoxemic resuscitation prevents pulmonary capillary endothelial dysfunction induced by normoxemic resuscitation from hemorrhagic shock. Critical Care Medicine 37: 869–875.PubMedCrossRef Douzinas, E.E., S.E. Orfanos, O. Livaditi, K. Augustatou, V. Villiotou, N. Kavantzas, A. Flevari, P. Korkolopoulou, C. Roussos, and E. Patsouris. 2009. Hypoxemic resuscitation prevents pulmonary capillary endothelial dysfunction induced by normoxemic resuscitation from hemorrhagic shock. Critical Care Medicine 37: 869–875.PubMedCrossRef
3.
go back to reference Kesik, V., A. Guven, S. Vurucu, T. Tunc, B. Uysal, G. Gundogdu, E. Oztas, and A. Korkmaz. 2009. Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. Journal of Surgical Research 157: e97–e105.PubMedCrossRef Kesik, V., A. Guven, S. Vurucu, T. Tunc, B. Uysal, G. Gundogdu, E. Oztas, and A. Korkmaz. 2009. Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. Journal of Surgical Research 157: e97–e105.PubMedCrossRef
4.
go back to reference Camara-Lemarroy, C.R., F.J. Guzman-de la Garza, G. Alarcon-Galvan, P. Cordero-Perez, L.E. Munoz-Espinosa, and N.E. Fernandez-Garza. 2010. Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion. Transplantation Proceedings 42: 1624–1626.PubMedCrossRef Camara-Lemarroy, C.R., F.J. Guzman-de la Garza, G. Alarcon-Galvan, P. Cordero-Perez, L.E. Munoz-Espinosa, and N.E. Fernandez-Garza. 2010. Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion. Transplantation Proceedings 42: 1624–1626.PubMedCrossRef
5.
go back to reference Oldenburg, W.A., L.L. Lau, T.J. Rodenberg, H.J. Edmonds, and C.D. Burger. 2004. Acute mesenteric ischemia: A clinical review. Archives of Internal Medicine 164: 1054–1062.PubMedCrossRef Oldenburg, W.A., L.L. Lau, T.J. Rodenberg, H.J. Edmonds, and C.D. Burger. 2004. Acute mesenteric ischemia: A clinical review. Archives of Internal Medicine 164: 1054–1062.PubMedCrossRef
6.
go back to reference Chen, J., J.C. Crispin, J. Dalle Lucca, and G.C. Tsokos. 2011. A novel inhibitor of the alternative pathway of complement attenuates intestinal ischemia/reperfusion-induced injury. Journal of Surgical Research 167: e131–e136.PubMedCrossRef Chen, J., J.C. Crispin, J. Dalle Lucca, and G.C. Tsokos. 2011. A novel inhibitor of the alternative pathway of complement attenuates intestinal ischemia/reperfusion-induced injury. Journal of Surgical Research 167: e131–e136.PubMedCrossRef
7.
go back to reference Choi, H.S., K.H. Jung, S.C. Lee, S.V. Yim, J.H. Chung, Y.W. Kim, W.K. Jeon, H.P. Hong, Y.G. Ko, C.H. Kim, K.H. Jang, and S.A. Kang. 2009. Bovine colostrum prevents bacterial translocation in an intestinal ischemia/reperfusion-injured rat model. Journal of Medicinal Food 12: 37–46.PubMedCrossRef Choi, H.S., K.H. Jung, S.C. Lee, S.V. Yim, J.H. Chung, Y.W. Kim, W.K. Jeon, H.P. Hong, Y.G. Ko, C.H. Kim, K.H. Jang, and S.A. Kang. 2009. Bovine colostrum prevents bacterial translocation in an intestinal ischemia/reperfusion-injured rat model. Journal of Medicinal Food 12: 37–46.PubMedCrossRef
8.
go back to reference Kay, L.J., W.W. Yeo, and P.T. Peachell. 2006. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. British Journal of Pharmacology 147: 707–713.PubMedCrossRef Kay, L.J., W.W. Yeo, and P.T. Peachell. 2006. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. British Journal of Pharmacology 147: 707–713.PubMedCrossRef
9.
go back to reference Kaur, D., F. Hollins, L. Woodman, W. Yang, P. Monk, R. May, P. Bradding, and C.E. Brightling. 2006. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy 61: 1047–1053.PubMedCrossRef Kaur, D., F. Hollins, L. Woodman, W. Yang, P. Monk, R. May, P. Bradding, and C.E. Brightling. 2006. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy 61: 1047–1053.PubMedCrossRef
10.
go back to reference Su, M., E.Y. Chi, M.J. Bishop, and W.R. Henderson Jr. 1993. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. American Review of Respiratory Disease 147: 448–456.PubMed Su, M., E.Y. Chi, M.J. Bishop, and W.R. Henderson Jr. 1993. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. American Review of Respiratory Disease 147: 448–456.PubMed
11.
go back to reference Vural, K.M., H. Liao, M.C. Oz, and D.J. Pinsky. 2000. Effects of mast cell membrane stabilizing agents in a rat lung ischemia–reperfusion model. The Annals of Thoracic Surgery 69: 228–232.PubMedCrossRef Vural, K.M., H. Liao, M.C. Oz, and D.J. Pinsky. 2000. Effects of mast cell membrane stabilizing agents in a rat lung ischemia–reperfusion model. The Annals of Thoracic Surgery 69: 228–232.PubMedCrossRef
12.
go back to reference Caughey, G.H. 2007. Mast cell tryptases and chymases in inflammation and host defense. Immunological Reviews 217: 141–154.PubMedCrossRef Caughey, G.H. 2007. Mast cell tryptases and chymases in inflammation and host defense. Immunological Reviews 217: 141–154.PubMedCrossRef
13.
go back to reference Wang, H., and S. He. 2006. Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2. Cell Biology International 30: 688–697.PubMedCrossRef Wang, H., and S. He. 2006. Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2. Cell Biology International 30: 688–697.PubMedCrossRef
14.
go back to reference Wang, H., Y. Zheng, and S. He. 2006. Induction of release and up-regulated gene expression of interleukin (IL)-8 in A549 cells by serine proteinases. BMC Cell Biology 7: 22.PubMedCrossRef Wang, H., Y. Zheng, and S. He. 2006. Induction of release and up-regulated gene expression of interleukin (IL)-8 in A549 cells by serine proteinases. BMC Cell Biology 7: 22.PubMedCrossRef
15.
go back to reference Lan, R.S., G.A. Stewart, and P.J. Henry. 2002. Role of protease-activated receptors in airway function: A target for therapeutic intervention? Pharmacology and Therapeutics 95: 239–257.PubMedCrossRef Lan, R.S., G.A. Stewart, and P.J. Henry. 2002. Role of protease-activated receptors in airway function: A target for therapeutic intervention? Pharmacology and Therapeutics 95: 239–257.PubMedCrossRef
16.
go back to reference Dale, C., and N. Vergnolle. 2008. Protease signaling to G protein-coupled receptors: implications for inflammation and pain. Journal of Receptor and Signal Transduction Research 28: 29–37.PubMedCrossRef Dale, C., and N. Vergnolle. 2008. Protease signaling to G protein-coupled receptors: implications for inflammation and pain. Journal of Receptor and Signal Transduction Research 28: 29–37.PubMedCrossRef
17.
go back to reference Mullan, C.S., M. Riley, D. Clarke, A. Tatler, A. Sutcliffe, A.J. Knox, and L. Pang. 2008. Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism. American Journal of Respiratory Cell and Molecular Biology 38: 600–608.PubMedCrossRef Mullan, C.S., M. Riley, D. Clarke, A. Tatler, A. Sutcliffe, A.J. Knox, and L. Pang. 2008. Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism. American Journal of Respiratory Cell and Molecular Biology 38: 600–608.PubMedCrossRef
18.
go back to reference Hofbauer, B., A.K. Saluja, M. Bhatia, J.L. Frossard, H.S. Lee, L. Bhagat, and M.L. Steer. 1998. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 115: 1238–1247.PubMedCrossRef Hofbauer, B., A.K. Saluja, M. Bhatia, J.L. Frossard, H.S. Lee, L. Bhagat, and M.L. Steer. 1998. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 115: 1238–1247.PubMedCrossRef
19.
go back to reference Hei, Z.Q., X.L. Gan, P.J. Huang, J. Wei, N. Shen, and W.L. Gao. 2008. Influence of ketotifen, cromolyn sodium, and compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. BMC Gastroenterology 8: 42.PubMedCrossRef Hei, Z.Q., X.L. Gan, P.J. Huang, J. Wei, N. Shen, and W.L. Gao. 2008. Influence of ketotifen, cromolyn sodium, and compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. BMC Gastroenterology 8: 42.PubMedCrossRef
20.
go back to reference Zhao, X., M. Dib, X. Wang, B. Widegren, and R. Andersson. 2005. Influence of mast cells on the expression of adhesion molecules on circulating and migrating leukocytes in acute pancreatitis-associated lung injury. Lung 183: 253–264.PubMedCrossRef Zhao, X., M. Dib, X. Wang, B. Widegren, and R. Andersson. 2005. Influence of mast cells on the expression of adhesion molecules on circulating and migrating leukocytes in acute pancreatitis-associated lung injury. Lung 183: 253–264.PubMedCrossRef
21.
go back to reference McNeil, H.P., K. Shin, I.K. Campbell, I.P. Wicks, R. Adachi, D.M. Lee, and R.L. Stevens. 2008. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis and Rheumatism 58: 2338–2346.PubMedCrossRef McNeil, H.P., K. Shin, I.K. Campbell, I.P. Wicks, R. Adachi, D.M. Lee, and R.L. Stevens. 2008. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis and Rheumatism 58: 2338–2346.PubMedCrossRef
22.
go back to reference Kalin, T.V., L. Meliton, A.Y. Meliton, X. Zhu, J.A. Whitsett, and V.V. Kalinichenko. 2008. Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. American Journal of Respiratory Cell and Molecular Biology 39: 390–399.PubMedCrossRef Kalin, T.V., L. Meliton, A.Y. Meliton, X. Zhu, J.A. Whitsett, and V.V. Kalinichenko. 2008. Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. American Journal of Respiratory Cell and Molecular Biology 39: 390–399.PubMedCrossRef
23.
go back to reference Isozaki, Y., N. Yoshida, M. Kuroda, O. Handa, T. Takagi, S. Kokura, H. Ichikawa, Y. Naito, T. Okanoue, and T. Yoshikawa. 2006. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis. Scandinavian Journal of Gastroenterology 41: 944–953.PubMedCrossRef Isozaki, Y., N. Yoshida, M. Kuroda, O. Handa, T. Takagi, S. Kokura, H. Ichikawa, Y. Naito, T. Okanoue, and T. Yoshikawa. 2006. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis. Scandinavian Journal of Gastroenterology 41: 944–953.PubMedCrossRef
24.
go back to reference Meyer, M.C., M.H. Creer, and J. McHowat. 2005. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. American Journal of Physiology. Cell Physiology 289: C1485–C1491.PubMedCrossRef Meyer, M.C., M.H. Creer, and J. McHowat. 2005. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. American Journal of Physiology. Cell Physiology 289: C1485–C1491.PubMedCrossRef
25.
go back to reference He, S., and H. Xie. 2005. Modulation of tryptase release from human tonsil mast cells by protease inhibitors. Pharmacological Reports 57: 523–530.PubMed He, S., and H. Xie. 2005. Modulation of tryptase release from human tonsil mast cells by protease inhibitors. Pharmacological Reports 57: 523–530.PubMed
26.
go back to reference Ostrowska, E., E. Sokolova, and G. Reiser. 2007. PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release. American Journal of Physiology. Lung Cellular and Molecular Physiology 293: L1208–L1218.PubMedCrossRef Ostrowska, E., E. Sokolova, and G. Reiser. 2007. PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release. American Journal of Physiology. Lung Cellular and Molecular Physiology 293: L1208–L1218.PubMedCrossRef
27.
go back to reference Moriyuki, K., F. Sekiguchi, K. Matsubara, H. Nishikawa, and A. Kawabata. 2009. Proteinase-activated receptor-2-triggered prostaglandin E(2) release, but not cyclooxygenase-2 upregulation, requires activation of the phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB pathway in human alveolar epithelial cells. Journal of Pharmacological Sciences 111: 269–275.PubMedCrossRef Moriyuki, K., F. Sekiguchi, K. Matsubara, H. Nishikawa, and A. Kawabata. 2009. Proteinase-activated receptor-2-triggered prostaglandin E(2) release, but not cyclooxygenase-2 upregulation, requires activation of the phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB pathway in human alveolar epithelial cells. Journal of Pharmacological Sciences 111: 269–275.PubMedCrossRef
28.
go back to reference Tanaka, Y., F. Sekiguchi, H. Hong, and A. Kawabata. 2008. PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochemical and Biophysical Research Communications 377: 622–626.PubMedCrossRef Tanaka, Y., F. Sekiguchi, H. Hong, and A. Kawabata. 2008. PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochemical and Biophysical Research Communications 377: 622–626.PubMedCrossRef
29.
go back to reference Krupa, A., R. Fudala, D. Stankowska, T. Loyd, T.C. Allen, M.A. Matthay, Z. Gryczynski, I. Gryczynski, Y.V. Mettikolla, and A.K. Kurdowska. 2009. Anti-chemokine autoantibody:chemokine immune complexes activate endothelial cells via IgG receptors. American Journal of Respiratory Cell and Molecular Biology 41: 155–169.PubMedCrossRef Krupa, A., R. Fudala, D. Stankowska, T. Loyd, T.C. Allen, M.A. Matthay, Z. Gryczynski, I. Gryczynski, Y.V. Mettikolla, and A.K. Kurdowska. 2009. Anti-chemokine autoantibody:chemokine immune complexes activate endothelial cells via IgG receptors. American Journal of Respiratory Cell and Molecular Biology 41: 155–169.PubMedCrossRef
30.
go back to reference Nakamura, M., S. Fujishima, M. Sawafuji, A. Ishizaka, T. Oguma, K. Soejima, H. Matsubara, S. Tasaka, K. Kikuchi, K. Kobayashi, E. Ikeda, M. Sadick, C.A. Hebert, N. Aikawa, M. Kanazawa, and K. Yamaguchi. 2000. Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. American Journal of Respiratory and Critical Care Medicine 161: 1030–1036.PubMed Nakamura, M., S. Fujishima, M. Sawafuji, A. Ishizaka, T. Oguma, K. Soejima, H. Matsubara, S. Tasaka, K. Kikuchi, K. Kobayashi, E. Ikeda, M. Sadick, C.A. Hebert, N. Aikawa, M. Kanazawa, and K. Yamaguchi. 2000. Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. American Journal of Respiratory and Critical Care Medicine 161: 1030–1036.PubMed
31.
go back to reference Yoshida, N., T. Takagi, Y. Isozaki, T. Suzuki, H. Ichikawa, and T. Yoshikawa. 2011. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats. Molecular Medicine Report 4: 81–86. Yoshida, N., T. Takagi, Y. Isozaki, T. Suzuki, H. Ichikawa, and T. Yoshikawa. 2011. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats. Molecular Medicine Report 4: 81–86.
32.
go back to reference Itoh, Y., T. Sendo, and R. Oishi. 2005. Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. Journal of Pharmacological Sciences 97: 14–19.PubMedCrossRef Itoh, Y., T. Sendo, and R. Oishi. 2005. Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. Journal of Pharmacological Sciences 97: 14–19.PubMedCrossRef
33.
go back to reference Su, X., and M.A. Matthay. 2009. Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis. Anatomical Record (Hoboken) 292: 580–586.CrossRef Su, X., and M.A. Matthay. 2009. Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis. Anatomical Record (Hoboken) 292: 580–586.CrossRef
34.
go back to reference Zhao, X., J.R. Town, A. Yang, X. Zhang, N. Paur, G. Sawicki, and J.R. Gordon. 2010. A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury. Journal of Surgical Research 162: 264–273.PubMedCrossRef Zhao, X., J.R. Town, A. Yang, X. Zhang, N. Paur, G. Sawicki, and J.R. Gordon. 2010. A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury. Journal of Surgical Research 162: 264–273.PubMedCrossRef
Metadata
Title
Mast-Cell-Releasing Tryptase Triggers Acute Lung Injury Induced by Small Intestinal Ischemia–Reperfusion by Activating PAR-2 in Rats
Authors
Xiaoliang Gan
Dezhao Liu
Pinjie Huang
Wanling Gao
Xinzhi Chen
Ziqing Hei
Publication date
01-06-2012
Publisher
Springer US
Published in
Inflammation / Issue 3/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9422-5

Other articles of this Issue 3/2012

Inflammation 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine